Under the National Tuberculosis Elimination Programme (NTEP), the treatment regimen for a new drug-sensitive TB patient in the intensive phase consists of:
- A 2HRZ followed by 4HR (2 months intensive, 4 months continuation)
- B 2HRZE followed by 4HR (2 months intensive, 4 months continuation) ✓
- C 2SHRZ followed by 6HR
- D 6HRE throughout
Correct answer: B. 2HRZE followed by 4HR (2 months intensive, 4 months continuation)
Explanation
Under NTEP (formerly RNTCP), the current daily regimen for new drug-sensitive pulmonary TB is 2HRZE (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol for 2 months) followed by 4HR (Isoniazid and Rifampicin for 4 months). Ethambutol replaced Streptomycin as the fourth drug in the intensive phase. Weight-based fixed-dose combinations (FDCs) are used under daily directly observed treatment.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.